| P50 | author | Rama Rao Amara | Q88444844 |
| | Suraj B. Sable | Q55188035 |
| P2093 | author name string | James E Posey | |
| | Bonnie B Plikaytis | |
| | Sunita Sharma | |
| | Thomas M Shinnick | |
| | Subhadra Nandakumar | |
| | Kathryn L Kellar | |
| | Kakali Bandyopadhyay | |
| | Mani Cheruvu | |
| P2860 | cites work | Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis | Q21256673 |
| | Future Vaccination Strategies against Tuberculosis: Thinking outside the Box | Q22252427 |
| | A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers | Q24657992 |
| | Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model | Q24675231 |
| | Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity | Q28269283 |
| | The population dynamics and control of tuberculosis | Q28282446 |
| | Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 |
| | Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model. | Q30352384 |
| | Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern. | Q30804006 |
| | Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose | Q33468422 |
| | Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes | Q33591737 |
| | Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae | Q33617454 |
| | Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice | Q33839055 |
| | The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults | Q33950119 |
| | Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis | Q34000833 |
| | Deglycosylation of the 45/47-kilodalton antigen complex of Mycobacterium tuberculosis decreases its capacity to elicit in vivo or in vitro cellular immune responses | Q34002292 |
| | Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages | Q34005306 |
| | Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization | Q34120343 |
| | Improved tuberculosis DNA vaccines by formulation in cationic lipids | Q34126930 |
| | Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice | Q34309667 |
| | Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans | Q34361636 |
| | Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? | Q34401214 |
| | Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. | Q34525095 |
| | T cell immunity in lymphoid and non-lymphoid tissues | Q34712720 |
| | The Apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model | Q34854931 |
| | Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis | Q35606285 |
| | Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells | Q35823499 |
| | Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis | Q35927959 |
| | The bone marrow: a nest for migratory memory T cells. | Q36174862 |
| | The success and failure of BCG - implications for a novel tuberculosis vaccine | Q36191944 |
| | Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis | Q36229158 |
| | Noninvasive delivery technologies: respiratory delivery of vaccines | Q36349694 |
| | Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection | Q36593990 |
| | Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity. | Q36701672 |
| | Should a new tuberculosis vaccine be administered intranasally? | Q36744991 |
| | Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria | Q36974497 |
| | Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein activates dendritic cells and induces a Th1 polarization | Q37256545 |
| | Is intranasal vaccination a feasible solution for tuberculosis? | Q37316013 |
| | A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice | Q37623702 |
| | Tuberculosis: what we don't know can, and does, hurt us. | Q37751647 |
| | Aerosol vaccines for tuberculosis: A fine line between protection and pathology | Q37808562 |
| | Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis | Q38451771 |
| | Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins | Q40273548 |
| | Nanobead-based interventions for the treatment and prevention of tuberculosis | Q44117645 |
| | Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis | Q44681127 |
| | Novel prophylactic and therapeutic vaccine against tuberculosis | Q44792823 |
| | Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara | Q45722508 |
| | Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis | Q46572484 |
| | Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology | Q47895673 |
| | Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu. | Q51483271 |
| | Envisioning future strategies for vaccination against tuberculosis. | Q53230123 |
| | Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis. | Q53938703 |
| | Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. | Q54453283 |
| | Recombinant GroES in combination with CpG oligodeoxynucleotides protects mice against Mycobacterium avium infection. | Q54534077 |
| | The Influence of Remaining Live BCG Organisms in Vaccinated Mice on the Maintenance of Immunity to Tuberculosis | Q58827830 |
| | A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis | Q62607993 |
| | Natural history of pertussis antibody in the infant and effect on vaccine response | Q68727725 |
| | Isolation and characterization of mouse nasal-associated lymphoid tissue | Q73233436 |
| | Role of a bacillus Calmette-Guérin fibronectin attachment protein in BCG-induced antitumor activity | Q73574127 |
| | Intranasal vaccination of mice against infection with Mycobacterium tuberculosis | Q73930782 |
| | The Mycobacterium tuberculosis cell-surface glycoprotein apa as a potential adhesin to colonize target cells via the innate immune system pulmonary C-type lectin surfactant protein A | Q79422100 |
| | Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration | Q79870527 |
| | Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice | Q80485791 |
| | Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis | Q81795473 |
| | Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice | Q82406166 |
| | Airway luminal T cells: a newcomer on the stage of TB vaccination strategies | Q84393604 |
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | e22718 | |
| P577 | publication date | 2011-07-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination | |
| P478 | volume | 6 | |